Brenda Larsen-Becker - 05 Jun 2025 Form 4 Insider Report for Sight Sciences, Inc. (SGHT)

Reporting relationship: Director
Issuer ticker: SGHT
Reported as of: 05 Jun 2025
Net transaction value: $0
SEC form: 4
Accepted by SEC: 09 Jun 2025, 21:54:50 UTC
Prior SEC filing: 10 Jun 2024
Source filing: View source filing
Reporting owner signature: /s/ Jeremy Hayden, Attorney-in-Fact for Brenda Larsen-Becker

Key filing fact

Brenda Larsen-Becker filed Form 4 for Sight Sciences, Inc. (SGHT) on 09 Jun 2025.

Key facts

This page summarizes Brenda Larsen-Becker's Form 4 filing for Sight Sciences, Inc. (SGHT).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 09 Jun 2025, 21:54.

Change

Previous filing in this sequence was filed on 10 Jun 2024.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001913647 Primary reporting owner

Larsen-Becker Brenda Jane

Relationship: Director
Address: C/O SIGHT SCIENCES, INC., 4040 CAMPBELL AVE., SUITE 100, MENLO PARK
Signature: /s/ Jeremy Hayden, Attorney-in-Fact for Brenda Larsen-Becker
Signature date: 09 Jun 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

SGHT transaction

Common Stock

Award

Transaction value: $0
Shares: +30,952
Change %: +64%
Price: $0.000000
Shares after: 79,040
Date: 05 Jun 2025
Ownership: Direct
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Reflects a grant of restricted stock units ("RSUs") made to the Reporting Person under the Issuer's Non-Employee Director Compensation Program. Each RSU represents a contingent right to receive one share of the Issuer's common stock, par value $0.001 per share ("Common Stock"). The number of RSUs granted is equal to approximately $130,000 of shares of Common Stock as determined by the closing price on the grant date, June 5, 2025. The RSUs vest on the earlier of June 5, 2026 and the date of the Issuer's 2026 annual meeting of stockholders, subject to the Reporting Person's continued service as a director on the Company's board of directors through such vesting date.

Footnote F2

Includes (i) 48,088 shares of Common Stock, and (ii) 30,952 RSUs which are subject to vesting as reported herein.